Multi-Model Predictive Controller for Insulin Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current artificial pancreas systems lack effective control methods to manage abrupt and slow variations in glucose dynamics, relying on limited control algorithms that struggle with constant or slowly changing glucose levels, and do not adequately handle rapid changes.

Innovation Solution

A closed-loop system that includes a medication delivery device and a controller with control logic to calculate a bolus delivery schedule, comprising an initial and delayed bolus delivery amount based on pre-meal glucose levels, using insulin and pramlintide, and employing a multi-model predictive controller algorithm to adapt to changing glucose conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional control algorithms are used in artificial pancreas systems, then the system can operate with simple control logic, but the system cannot effectively handle abrupt variations in glucose dynamics

Engineering Contradiction:
Improveability to handle abrupt glucose variationsVSAvoidcontrol algorithm complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The control algorithm transitions from static to dynamic by incorporating multiple models that can adapt to changing glucose dynamics. The system switches between different models based on the current glucose state, enabling it to respond to both abrupt and slow variations in glucose levels without requiring overly complex control logic.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system changes control parameters dynamically by selecting different models with varying parameters based on the current glucose situation. This allows the algorithm to adjust its behavior to match the specific glucose dynamics being experienced, improving adaptability while maintaining manageable complexity through parameter selection rather than structural complexity.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If a single fixed insulin model is used, then the control algorithm is simple to implement, but the model cannot accurately represent varying insulin dynamics in different glucose conditions

Engineering Contradiction:
Improveaccuracy of insulin modelVSAvoidmodel structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The single insulin model is segmented into multiple models, each representing different insulin dynamics under specific glucose conditions. This segmentation allows the system to select the appropriate model for the current situation, improving accuracy without requiring a single overly complex model that attempts to represent all possible conditions simultaneously.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The insulin model transitions from a fixed, static representation to a dynamic multi-model structure that can adapt to changing glucose conditions. The system dynamically selects which insulin model to use based on the current glucose state, ensuring accurate representation of insulin dynamics across varying conditions while maintaining implementation simplicity through modular model selection.

Inventive Principle:
Principle #15Dynamics

3Speed

If rapid response to glucose changes is implemented, then glycemic control improves, but the risk of oscillations and instability increases

Engineering Contradiction:
Improveresponse speed to glucose changesVSAvoidglucose level stability
Core Design Contradiction:
SpeedVSStability of the object's composition

Solution Approach 1:

The control algorithm dynamically adjusts its response characteristics based on the current glucose situation. By selecting appropriate models for different glucose states, the system can respond rapidly to acute changes when necessary while maintaining stability during steady-state conditions, avoiding the oscillations that would result from a consistently aggressive control approach.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system changes control parameters based on the selected model, allowing rapid response when glucose dynamics require it while maintaining stability during normal conditions. This parameter adaptation enables the system to achieve both fast response and stability by adjusting its behavior to match the specific glucose situation rather than using fixed aggressive control parameters.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20240312591A1Insulin and pramlintide delivery systems, methods, and devices
Publication Date: 2024.09.19 MYLIFE DIABETES CARE AG
  • US20240312591A1 patent drawing
  • US20240312591A1 patent drawing
  • US20240312591A1 patent drawing

AI summary

The present disclosure relates to systems and methods for controlling physiological glucose concentrations in a patient.